ing factor (CRF) (Ishi¬ bashi & Yamaji 1978 , 1984 Adams et al. 1979) while such an effect of TRH could not be demon¬ strated in normal human somatotrophs in vitro (Ishibashi & Yamaji 1984) .
Recently, corticotrophin-releasing factor (CRF) has been isolated from ovine hypothalamic extracts and its primary structure determined Spiess et al. 1981) . Synthetic ovine CRF is shown to be a potent and specific secretagogue for ACTH both in vivo (Rivier et al. 1982) and in vitro (Ishibashi et al. 1977; Ishibashi & Yamaji 1978 , 1984 The amounts of GH accumulated in the media during the pre-incubation ranged from 34.2 ± 2.6 (mean ± SEM, = 21) (No. 5 in Fig. 1 In order to study the interaction of CRF and glu¬ cocorticoids on GH secretion, cultured adenoma cells from acromegalie patients were co-incubated with ovine CRF and hydrocortisone (Fig. 2) Ovine CRF has been shown to be a potent and specific secretagogue for ACTH in man (Orth et al. 1983 ) as well as in experimental animals (Rivier et al. 1982) . No increase in the circulating levels of GH was observed in normal individuals after the injection of CRF even when a dose as high as 30 µg/kg body weight was employed (Orth et al. 1983 (No. 4 in Fig. 2 
